Impact of diabetes mellitus on the clinical management of global cardiovascular risk: Analysis of the results of the evaluation of final feasible effect of control training and ultra sensitization (EFFECTUS) educational program

Clinical Cardiology

Volumn 34, Issue 9, 2011, Pages 560-566

  Tocci, Giuliano ^a   Ferrucci, Andrea ^a   Guida, Pietro ^b   Avogaro, Angelo ^c   Comaschi, Marco ^d   Corsini, Alberto ^e   Cortese, Claudio ^f   Giorda, Carlo Bruno ^g   Manzato, Enzo ^c   Medea, Gerardo ^h   Mureddu, Gian Francesco ⁱ   Riccardi, Gabriele ^j   Titta, Giulio ^k   Ventriglia, Giuseppe ^h   Zito, Giovanni Battista ^l   Volpe, Massimo ^a,m  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g Metabolism and Diabetes Unit   (Italy)

^h Italian College of General Practice (SIMG)   (Italy)

ⁱ Hospital San Giovanni Addolorata   (Italy)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^k Italian Federation of General Medicine   (Italy)

^l ASL Napoli 3 Sud   (Italy)

^m IRCCS NEUROMED   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GHRELIN RECEPTOR; GLITAZONE DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NITRATE; OMEGA 3 FATTY ACID; TICLOPIDINE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTPATIENT; PHYSICAL ACTIVITY; PHYSICIAN; RISK ASSESSMENT; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIOVASCULAR DISEASES; CLINICAL COMPETENCE; DIABETES MELLITUS; EDUCATIONAL STATUS; FEASIBILITY STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PHYSICIANS; PREVALENCE; PROGRAM EVALUATION; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 80052695290     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20937     Document Type: Article

References (20)

1. Kannel WB, McGee DL., Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979; 2: 120-126. (Pubitemid 9238733)
2. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16: 434-444. (Pubitemid 23046633)
3. Abbott RD, Donahue RP, Kannel WB, et al. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA. 1988; 260: 3456-3460. (Pubitemid 19003125)
4. Garcia MJ, McNamara PM, Gordon T, et al. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes. 1974; 23: 105-111.
5. Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358: 580-591. (Pubitemid 351214285)
6. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348: 383-393. (Pubitemid 36159355)
7. Volpe M, Tocci G, Avogaro A, et al. Global cardiovascular risk assessment in different clinical settings: basal results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) program. High Blood Press Cardiovasc Prev. 2009; 16: 55-63.
8. Tocci G, Ferrucci A, Guida P, et al. Global cardiovascular risk management in different Italian regions: an analysis of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) educational program. Nutr Metab Cardiovasc Dis. 2010; doi:10.1016/j.numecd.2010. 10.009.
9. Giorda CB, Guida P, Avogaro, A, et al. Association of physicians'accuracy in recording with quality of care in cardiovascular medicine. Eur J Cardiovasc Prev Rehabil. 2009; 16: 722-728.
10. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25: 1105-1187. (Pubitemid 46924065)
11. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-2497.
12. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109: 433-438. (Pubitemid 38133916)
13. Sesti G, Volpe M, Cosentino F, et al. Metabolic syndrome: diagnosis and clinical management, an official document of the Working Group of the Italian Society of Cardiovascular Prevention (SIPREC). High Blood Press Cardiovasc Prev. 2006; 13: 185-198. (Pubitemid 46105081)
14. Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007; 28: 88-136. (Pubitemid 46137814)
15. Volpe M, Borghi C, Cavallo Perin P, et al. Cardiovascular prevention in subjects with impaired fasting glucose or impaired glucose tolerance. High Blood Press Cardiovasc Prev. 2010; 17: 73-102.
16. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 (suppl 1): S62-S69.
17. Tocci G, Trimarco B, Mancia G, et al. Cardiovascular risk profile in 14,513 patients with essential hypertension followed by Italian specialist physicians. High Blood Press Cardiovasc Prev. 2004; 11: 165-173.
18. Volpe M, Notaro LA, Tocci G, et al. The REassessment of Antihypertensive Chronic Therapy (REACT) Study: an Italian observational study on hypertension management in patients with established therapy. High Blood Press Cardiovasc Prev. 2004; 11: 175-185.
19. Mancia G, Ambrosioni E, Rosei EA, et al. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens. 2005; 23: 1575-1581. (Pubitemid 41104830)
20. Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008; 31 (suppl 1): S61-S78.